InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Danos Olivier, Directeur Scientifique. Officer active across 1 companies, notably REGENXBIO Inc.. In total, 2 filings have been logged. The latest transaction was disclosed on 30 June 2021 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€15,457555 shares@ €27.8512100.0% of flow
Common Stock
SEC:0001562180-22-000156·
€15,457555 shares@ €27.85120.0052% mcap50.0% of flow
Common Stock
SEC:0001562180-22-000156:0·
2 of 2 declarations
About Danos Olivier
Olivier Danos is the Chief Scientific Officer at REGENXBIO Inc., a biopharmaceutical company specializing in gene therapy. He is responsible for research and development of new therapies. His role is crucial in driving innovation and ensuring the effectiveness of developed products.
